EW logo

Edwards Lifesciences (EW) Accounts Receivable

Annual Accounts Receivable

$775.10 M
+$132.10 M+20.54%

December 31, 2023


Summary


Performance

EW Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEWbalance sheetmetrics:

Quarterly Accounts Receivable

$716.00 M
-$62.30 M-8.00%

September 30, 2024


Summary


Performance

EW Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEWbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

EW Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+20.5%-3.2%
3 y3 years+50.6%+19.2%
5 y5 years+69.6%+25.6%

EW Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+33.1%-12.4%+23.0%
5 y5-yearat high+50.6%-12.4%+39.1%
alltimeall timeat high+808.7%-12.4%+739.4%

Edwards Lifesciences Accounts Receivable History

DateAnnualQuarterly
Sep 2024
-
$716.00 M(-8.0%)
Jun 2024
-
$778.30 M(-4.8%)
Mar 2024
-
$817.60 M(+5.5%)
Dec 2023
$775.10 M(+20.5%)
$775.10 M(+4.8%)
Sep 2023
-
$739.80 M(-1.9%)
Jun 2023
-
$754.40 M(+5.1%)
Mar 2023
-
$717.70 M(+11.6%)
Dec 2022
$643.00 M(+10.4%)
$643.00 M(+4.0%)
Sep 2022
-
$618.10 M(-2.9%)
Jun 2022
-
$636.40 M(+0.0%)
Mar 2022
-
$636.30 M(+9.3%)
Dec 2021
$582.20 M(+13.1%)
$582.20 M(-3.1%)
Sep 2021
-
$600.60 M(-6.2%)
Jun 2021
-
$640.50 M(+9.2%)
Mar 2021
-
$586.60 M(+14.0%)
Dec 2020
$514.60 M(-5.3%)
$514.60 M(-6.4%)
Sep 2020
-
$549.70 M(-3.2%)
Jun 2020
-
$567.90 M(-2.9%)
Mar 2020
-
$585.10 M(+7.6%)
Dec 2019
$543.60 M(+19.0%)
$543.60 M(-4.6%)
Sep 2019
-
$570.00 M(-6.5%)
Jun 2019
-
$609.60 M(+5.5%)
Mar 2019
-
$578.00 M(+26.5%)
Dec 2018
$456.90 M(+4.1%)
$456.90 M(+7.8%)
Sep 2018
-
$423.80 M(-1.8%)
Jun 2018
-
$431.40 M(+6.1%)
Mar 2018
-
$406.60 M(-7.3%)
Dec 2017
$438.70 M(+20.0%)
$438.70 M(-7.6%)
Sep 2017
-
$475.00 M(-7.0%)
Jun 2017
-
$510.70 M(+0.1%)
Mar 2017
-
$510.20 M(+39.6%)
Dec 2016
$365.50 M(+15.9%)
$365.50 M(-19.5%)
Sep 2016
-
$454.20 M(+6.7%)
Jun 2016
-
$425.80 M(+9.6%)
Mar 2016
-
$388.50 M(+23.2%)
Dec 2015
$315.40 M(+9.5%)
$315.40 M(-6.8%)
Sep 2015
-
$338.40 M(-3.6%)
Jun 2015
-
$351.00 M(+1.7%)
Mar 2015
-
$345.30 M(+19.9%)
Dec 2014
$288.00 M(-4.8%)
$288.00 M(-10.8%)
Sep 2014
-
$322.90 M(-1.4%)
Jun 2014
-
$327.50 M(+7.3%)
Mar 2014
-
$305.10 M(+0.9%)
Dec 2013
$302.50 M(-5.8%)
$302.50 M(-7.7%)
Sep 2013
-
$327.80 M(-4.1%)
Jun 2013
-
$341.80 M(+3.7%)
Mar 2013
-
$329.70 M(+2.7%)
Dec 2012
$321.10 M
$321.10 M(-1.3%)
DateAnnualQuarterly
Sep 2012
-
$325.40 M(-3.3%)
Jun 2012
-
$336.40 M(-3.0%)
Mar 2012
-
$346.70 M(+22.2%)
Dec 2011
$283.80 M(+2.3%)
$283.80 M(-18.2%)
Sep 2011
-
$346.80 M(-4.8%)
Jun 2011
-
$364.10 M(+2.8%)
Mar 2011
-
$354.20 M(+27.7%)
Dec 2010
$277.30 M(+11.2%)
$277.30 M(-8.6%)
Sep 2010
-
$303.40 M(+3.2%)
Jun 2010
-
$294.00 M(+5.5%)
Mar 2010
-
$278.60 M(+11.7%)
Dec 2009
$249.40 M(+33.9%)
$249.40 M(-11.1%)
Sep 2009
-
$280.50 M(+2.2%)
Jun 2009
-
$274.50 M(+7.3%)
Mar 2009
-
$255.80 M(+37.3%)
Dec 2008
$186.30 M(+60.9%)
$186.30 M(-12.8%)
Sep 2008
-
$213.60 M(+23.3%)
Jun 2008
-
$173.30 M(+11.6%)
Mar 2008
-
$155.30 M(+34.1%)
Dec 2007
$115.80 M(+3.9%)
$115.80 M(-15.3%)
Sep 2007
-
$136.70 M(-0.5%)
Jun 2007
-
$137.40 M(+6.3%)
Mar 2007
-
$129.30 M(+16.0%)
Dec 2006
$111.50 M(-5.9%)
$111.50 M(-14.4%)
Sep 2006
-
$130.20 M(-2.6%)
Jun 2006
-
$133.70 M(+8.7%)
Mar 2006
-
$123.00 M(+3.8%)
Dec 2005
$118.50 M(+13.8%)
$118.50 M(-5.9%)
Sep 2005
-
$125.90 M(+0.8%)
Jun 2005
-
$124.90 M(-2.2%)
Mar 2005
-
$127.70 M(+22.7%)
Dec 2004
$104.10 M(+6.8%)
$104.10 M(-8.0%)
Sep 2004
-
$113.20 M(+2.8%)
Jun 2004
-
$110.10 M(-3.0%)
Mar 2004
-
$113.50 M(+16.4%)
Dec 2003
$97.50 M(+10.4%)
$97.50 M(-15.7%)
Sep 2003
-
$115.60 M(-7.1%)
Jun 2003
-
$124.40 M(-0.4%)
Mar 2003
-
$124.90 M(+41.4%)
Dec 2002
$88.30 M(+3.5%)
$88.30 M(-22.0%)
Sep 2002
-
$113.20 M(-1.0%)
Jun 2002
-
$114.40 M(+4.7%)
Mar 2002
-
$109.30 M(+28.1%)
Dec 2001
$85.30 M(-20.3%)
$85.30 M(-28.3%)
Sep 2001
-
$119.00 M(+2.2%)
Jun 2001
-
$116.40 M(-14.5%)
Mar 2001
-
$136.20 M(+27.3%)
Dec 2000
$107.00 M(-19.5%)
$107.00 M
Dec 1999
$133.00 M
-

FAQ

  • What is Edwards Lifesciences annual accounts receivable?
  • What is the all time high annual accounts receivable for Edwards Lifesciences?
  • What is Edwards Lifesciences annual accounts receivable year-on-year change?
  • What is Edwards Lifesciences quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly accounts receivable year-on-year change?

What is Edwards Lifesciences annual accounts receivable?

The current annual accounts receivable of EW is $775.10 M

What is the all time high annual accounts receivable for Edwards Lifesciences?

Edwards Lifesciences all-time high annual accounts receivable is $775.10 M

What is Edwards Lifesciences annual accounts receivable year-on-year change?

Over the past year, EW annual accounts receivable has changed by +$132.10 M (+20.54%)

What is Edwards Lifesciences quarterly accounts receivable?

The current quarterly accounts receivable of EW is $716.00 M

What is the all time high quarterly accounts receivable for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly accounts receivable is $817.60 M

What is Edwards Lifesciences quarterly accounts receivable year-on-year change?

Over the past year, EW quarterly accounts receivable has changed by -$23.80 M (-3.22%)